ARDS - Aridis Pharmaceuticals Inc
N/A
0 0%
Share volume: 0
Last Updated: Fri 30 Aug 2024 11:00:08 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
36%
Profitability
43%
Dept financing
23%
Liquidity
37%
Performance
33%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.29%
Return on assets
-25.63%
Return on sales
-8920.5%
Return on invested capital
176.49%
Total debt ratio
63.14%
Debt ratio change over timeo
-0.11%
Current Ratio
3.96%
Quick Ratio
0%
Cash Position Ratio
2.43%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
25.33%
Return on assets
-23.75%
Return on sales
0%
Return on invested capital
61.49%
Total debt ratio
101.45%
Debt ratio change over timeo
0.86%
Current Ratio
1.68%
Quick Ratio
0%
Cash Position Ratio
1.15%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
69.48%
Return on assets
-23.35%
Return on sales
0%
Return on invested capital
27.58%
Total debt ratio
133.53%
Debt ratio change over time
2.26%
Current Ratio
0.78%
Quick Ratio
0%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-35.57%
Return on assets
-126.31%
Return on sales
-8358.27%
Return on invested capital
3.81%
Total debt ratio
-11.11%
Debt ratio change over time
-0.11%
Current Ratio
1.41%
Quick Ratio
0%
Cash Position Ratio
1.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARDS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.29% | -3.05% | 11.55% | 6.27% |
| Return on assets | -25.63% | 3.6% | 3.57% | 5.27% |
| Return on sales | -8920.5% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 176.49% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 63.14% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.11% | 6.09% | 6.03% | 1.53% |
| Dept financing | 16% | 50% | 43% | 14% |
| Current Ratio | 1.68% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.15% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 54% | 59% |
| Short-term ratios | ARDS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 25.33% | -25.62% | 17.94% | 7.14% |
| Return on assets | -23.75% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 61.49% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 41% | 65% | 62% |
| Total debt ratio | 101.45% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 0.86% | -23.44% | 9.66% | 0.6% |
| Dept financing | 26% | 25% | 45% | 8% |
| Current Ratio | 1.68% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.15% | 1.48% | 0.76% | 1.49% |
| Liquididy | 31% | 57% | 42% | 75% |